Parabronchial smooth muscle constitutes an airway epithelial stem cell niche in the mouse lung after injury by Volckaert, Thomas et al.
Research article
	 The	Journal	of	Clinical	Investigation      http://www.jci.org      Volume 121      Number 11      November 2011  4409
Parabronchial smooth muscle constitutes  
an airway epithelial stem cell niche  
in the mouse lung after injury
Thomas Volckaert,1,2,3 Erik Dill,1 Alice Campbell,1 Caterina Tiozzo,4 Susan Majka,5  
Saverio Bellusci,4,6 and Stijn P. De Langhe1
1Department of Pediatrics, Division of Cell Biology, National Jewish Health, Denver, Colorado, USA. 2Department for Molecular Biomedical Research,  
Unit of Molecular Signal Transduction in Inflammation, VIB, Ghent, Belgium. 3Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium. 
4Developmental Biology Program, Division of Surgery, Saban Research Institute of Children’s Hospital Los Angeles, Los Angeles, California, USA.  
5Department of Medicine, University of Colorado Denver, Aurora, Colorado, USA. 6Excellence Cluster in Cardio-Pulmonary Systems,  
























































Reactivation of Wnt signaling reinduces Fgf10 expression in PSMCs 3 days 





















BrdU  labeling of  lungs  3 days  after naphthalene-mediated 
epithelial injury indicated a robust proliferation of the PSMCs 
compared with  a  lack  of  prolif-
eration in corn oil–treated lungs 
(Figure  1,  A  and  B;  0%  ±  0%  vs. 

























naphthalene,  we  noticed  that 
the majority  of  Clara  cells  were 
lost at 3 days after challenge, but 







PSMCs  surrounding  the  injured 






















Wnt7b expressed by surviving ciliated cells induces Fgf10 expression in PSMCs 3 days after naphtha-
lene-mediated Clara cell injury. (A–C) Immunostaining for proliferation marker BrdU and SMC marker 
α-SMA on 2-month-old WT lungs 3 days after corn oil treatment (A), WT lungs 3 days after naphthalene 
(npt) treatment (B), and Rosa26-rtTa;Tet-Dkk1 lungs 3 days after naphthalene treatment (C). (D–F) 
β-gal staining on 2-month-old TOPGAL lungs 3 days after corn oil treatment (D), TOPGAL lungs 3 days 
after naphthalene treatment (E), and Rosa26-rtTa;Tet-Dkk1;TOPGAL lungs 3 days after naphthalene 
treatment (F). Arrow in E denotes TOPGAL activation in PSMCs. (G–I) β-gal staining on 2-month-old 
Fgf10LacZ lungs 3 days after corn oil treatment (G), Fgf10LacZ lungs 3 days after naphthalene treat-
ment (H), and Rosa26-rtTa;Tet-Dkk1;Fgf10LacZ lungs 3 days after naphthalene treatment (I). Insets 
are enlarged ×4. Note that we identified the blue cells in alveolar compartment as lipofibroblasts (S.P. 
De Langhe, unpublished observations). (J and K) Immunostaining for ciliated cell marker β-tubulin and 
Wnt7b on 2-month-old WT lungs 3 days after corn oil treatment (J) or naphthalene treatment (K). Insets 
are enlarged ×3. (L) qPCR analysis of relative Wnt7b and Wnt3a mRNA abundance in 2-month-old WT 
lungs 3 days after treatment with corn oil versus naphthalene. **P < 0.01 vs. respective control. n = 3. 
Scale bars: 100 μm (A–C, J, and K); 250 μm (D–F); 200 μm (G–I).
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Wnt-induced Fgf10 secreted by PSMCs is essential for epithelial repair after naphthalene injury. (A–C, G, H, L, and M) Immunostaining for 
Clara cell marker Scgb1a1 and ciliated cell marker β-tubulin on lungs 14 days after naphthalene treatment isolated from control (A), dox-induced 
Rosa26-rtTa;Tet-sFgfr2b (B), dox-induced Rosa26-rtTA;Tet-Fgf10 (C), dox-induced Rosa26-rtTa;Tet-Dkk1 (G), dox-induced Rosa26-rtTa; 
Tet-Dkk1;Tet-Fgf10 (H), Myh11-Cre–;Fgf10fl/fl (L), and Myh11-Cre+;Fgf10fl/fl (M) mice. (D–F, J, K, O, and P) Immunostaining for Scgb1a1 and 
neuroendocrine marker CGRP on lungs 14 days after naphthalene treatment isolated from control (D), dox-induced Rosa26-rtTa;Tet-sFgfr2b (E), 
dox-induced Rosa26-rtTA;Tet-Fgf10 (F), dox-induced Rosa26-rtTa;Tet-Dkk1 (J), dox-induced Rosa26-rtTa;Tet-Dkk1;Tet-Fgf10 (K), Myh11-Cre–; 
Fgf10fl/fl (O), and Myh11-Cre+;Fgf10fl/fl (P) mice. (I) qPCR analysis of relative Scgb1a1 mRNA abundance of adult lungs from control, Rosa26-rtTa; 
Tet-sFgfr2b, Rosa26-rtTA-Tet-Fgf10, Rosa26rtTa;Tet-Dkk1, and Rosa26-rtTa;Tet-Dkk1;Tet-Fgf10 mice 3, 7, and 14 days after naphthalene 
treatment. (N) qPCR analysis of relative Scgb1a1 mRNA abundance in lungs from 2-month-old Myh11-Cre–;Fgf10fl/fl and Myh11-Cre+;Fgf10fl/fl 
mice 14 days after naphthalene treatment. **P < 0.01, *P < 0.05 vs. respective control. n ≥ 3. Scale bars: 200 μm (A–C, G, H, L, and M); 100 μm 
(D–F, J, K, O, and P).
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Fgf10 mediates epithelial repair independent of Wnt ligands in part by activating/enhancing β-catenin signaling in the epithelium. β-gal staining 
(A–J) and β-gal staining with coimmunostaining for Scgb1a1 (K–O) or CGRP (P–T) on lungs 7 days after naphthalene treatment from TOPGAL 
(A, F, K, and P), dox-induced Rosa26-rtTA;Tet-Fgf10;TOPGAL (B, G, L, and Q), dox-induced Rosa26-rtTa;Tet-sFgfr2b;TOPGAL (C, H, M, and 
R), dox-induced Rosa26-rtTa;Tet-Dkk1;TOPGAL (D, I, N, and S), and dox-induced Rosa26-rtTa;Tet-Dkk1;Tet-Fgf10;TOPGAL mice (E, J, O, and 
T). Scale bars: 2,000 μm (A–E); 500 μm (F–J); 50 μm (K–T).
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Fgf10 mediates airway epithelial repair independent of Wnt ligands, in 






























Fgf10 signaling induces Akt-mediated phosphorylation of β-catenin and 










Fgf10 signaling induces Akt-mediated phos-
phorylation of β-catenin and maintenance/
amplification of variant Clara cells. (A–C) 
Immunostaining for p-Akt and Scgb1a1 on 
lungs from control (A), Rosa26-rtTa;Tet-
Fgf10 (B), and Rosa26-rtTA;Tet-sFgfr2b (C) 
mice 3 days after naphthalene treatment. 
(D–F) Immunostaining for p–β-catenin–
Ser552 and Scgb1a1 on lungs from control 
(D), Rosa26-rtTa;Tet-Fgf10 (E), and Rosa26-
rtTA;Tet-sFgfr2b (F) mice 3 days after naph-
thalene treatment. (G and H) Immunostaining 
for Scgb1a1 and Fgfr2b on lungs from con-
trol (G) and Rosa26-rtTa;Tet-Fgf10 (H) mice 
21 days after naphthalene treatment. White 
outlines denote the epithelium at the BADJ. 
(I and J) Immunostaining for BASC markers 
Scgb1a1 and Sftpc on lungs from control (I) 
and Rosa26-rtTa;Tet-Fgf10 (J) mice 21 days 
after naphthalene treatment. (K) Immuno-
staining for CGRP and Sftpc on lungs from 
Rosa26-rtTa;Tet-Fgf10 mice 21 days after 
naphthalene treatment. Scale bars: 50 μm 
(A–F and K); 100 μm (G–J).
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Flow cytometry analysis of Scgb1a1-Sftpc or Scgb1a1-Fgfr2 double-posi-





















Fgf10 signaling induces Fgfr2b expression, Notch activation, and subse-




Flow cytometry analysis of airway epithelial stem cells. Flow cytometry analysis using Sftpc and Scgb1a1 (A, C, and E) versus Fgfr2 and 
Scgb1a1 (B, D, and F) antibodies on permeabilized epithelial cells from WT noninjured lungs (A and B), WT lungs 7 days after naphthalene injury 
(C and D), and Rosa26-rtTa;Tet-Fgf10 lungs 7 days after naphthalene injury (E and F). A 14-fold increase in double-positive airway epithelial 
cells was detected with both antibody combinations 7 days after naphthalene injury; a 22- to 33-fold increase was seen 7 days after injury in 
mice overexpressing Fgf10. Forward scatter/side scatter (FS/SS) plots indicated that the same pool of airway epithelial stem cells was isolated 
using either antibody combination.
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Variant Clara cells undergo a transient EMT in response to Fgf10-induced 


















Fgf10 signaling induces Fgfr2b expression, Notch activation, and subsequent Snail induction in the activated variant Clara cells. Immunostaining 
for CGRP and Fgfr2b (A–E), Scgb1a1 and NotchICD (active notch) (F–J), CGRP and NotchICD (K–O), and CGRP and Snail1 (P–T) on lungs 
from control (A, F, K, and P), dox-induced Rosa26-rtTa;Tet-Fgf10 (B, G, L, and Q), dox-induced Rosa26-rtTA;Tet-sFgfr2b (C, H, M, and R), 
dox-induced Rosa26-rtTa;Tet-Dkk1 (D, I, N, and S), and dox-induced Rosa26-rtTa;Tet-Dkk1;Tet-Fgf10 (E, J, O, and T) mice 3 days after naph-
thalene treatment. Scale bar: 50 μm (A–T).
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ing,  induces  Snai1  expression 
























jured  lungs  from Scgb1a1-rtTa; 
Tet-O-Cre;Rosa26-NotchICD mice 




















Clara  cells  undergoing  repair 
was  important  for  the  proper 
restoration and function of the 
Figure 7
Variant Clara cells undergo transient EMT in response to Fgf10-induced Notch activation and subsequent 
Snail induction. (A–C) Lineage tracing of activated variant Clara cells that underwent transient EMT in 
Myh11-Cre;Rosa26-LacZ mice 3 (A) and 7 (B and C) days after naphthalene injury. (C) Lower-magnifica-
tion view of B. (D and E) Lineage tracing of activated variant Clara cells that underwent transient EMT in 
Myh11-Cre;Rosa26-eYFP mice 7 days after naphthalene injury, shown by immunostaining for GFP and 
CGRP (D) or GFP and Scgb1a1 (E). (F) qPCR analysis of relative Scgb1a1 mRNA abundance in lungs from 
2-month-old control and Scgb1a1-rtTa;Tet-o-Cre;Rosa26-NotchICD mice 3 and 7 days after naphthalene 
treatment. (G and H) Immunostaining for NotchICD and Scgb1a1 on noninjured (NI) lungs from control (G) 
and Rosa26-rtTa;Tet-Fgf10 mice (H) 14 days after dox treatment. (I) Immunostaining for Snail1 and Scgb1a1 
on noninjured lungs from Scgb1a1-rtTa;Tet-o-Cre;Rosa26-NotchICD+/– mice 14 days after dox treatment. 
(J and K) Immunostaining for Scgb1a1 and β-tubulin on lungs from control (J) and Shh-Cre+;Snai1fl/fl (K) 
mice 14 days after naphthalene treatment. (L) qPCR analysis of relative Scgb1a1 mRNA abundance in lungs 
from 2-month-old control and Shh-Cre+;Snai1fl/fl mice 7 and 14 days after naphthalene treatment. (M–O) 
Lineage tracing of activated variant Clara cells that underwent transient EMT in Myh11-Cre;Rosa26-LacZ 
(M), Myh11-Cre;Rosa26-LacZ;Rosa26-rtTa;Tet-Dkk1 (N), and Myh11-Cre;Rosa26-LacZ;Rosa26-rtTA; 
Tet-sFgfr2b (O) mice 14 days after naphthalene injury. Insets are enlarged ×4. **P < 0.01, *P < 0.05 vs. 
control. n ≥ 3. Scale bars: 50 μm (A, B, E, and G–I); 200 μm (C, J, K, and M–O); 31.7 μm (D).
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Model of PSMC progenitors during development and recapitula-
tion of a progenitor state by mature PSMCs after naphthalene 
injury. (A) During embryonic lung development, PSMC progeni-
tors are identified as Fgf10-expressing cells in the distal mesen-
chyme (10). The amplification of these PSMC progenitors as well 
as their Fgf10 expression is regulated by mesenchymal β-catenin 
signaling (9). Fgf10 signaling is critical during lung development 
in the maintenance of lung epithelial progenitors (5, 8, 13). (B) In 
the adult lung, Fgf10 expression in mature PSMCs is silenced. 
Upon naphthalene administration, Clara cells are destroyed 
— except for variant Clara cells — at both NEBs and BADJs. 
Ciliated cells spread out to cover the basement membrane (BM) 
and induce Wnt7b expression. Wnt7b then acts on the PSMCs to 
reactivate Fgf10 expression, which then acts on the variant Clara 
cells to activate Notch signaling and induce expression of Fgfr2b, 
Sftpc, and Snail1, thereby initiating the repair process through a 
transient EMT. ATI, alveolar type I cell; ATII, alveolar type II cell; 
NEB, neuroendocrine body.
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